206 related articles for article (PubMed ID: 17201231)
1. The expanding role of leukotriene receptor antagonists in chronic asthma.
Currie GP; McLaughlin K
Ann Allergy Asthma Immunol; 2006 Dec; 97(6):731-41, quiz 741-2, 793. PubMed ID: 17201231
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy for allergic rhinitis: a critical review of leukotriene receptor antagonists compared with other treatments.
Nathan RA
Ann Allergy Asthma Immunol; 2003 Feb; 90(2):182-90; quiz 190-1, 232. PubMed ID: 12602664
[TBL] [Abstract][Full Text] [Related]
3. Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review.
Colucci R; Fornai M; Tuccori M; Antonioli L; Pasqualetti G; Blandizzi C; Del Tacca M
J Asthma; 2007; 44(6):411-22. PubMed ID: 17654125
[TBL] [Abstract][Full Text] [Related]
4. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
Wahn U; Dass SB
Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
[TBL] [Abstract][Full Text] [Related]
5. Treating asthma: is there a place for leukotriene receptor antagonists?
Diamant Z; van der Molen T
Respir Med; 2005 Jun; 99(6):655-62. PubMed ID: 15878481
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic modulation of allergic airways disease with leukotriene receptor antagonists.
Currie GP; Srivastava P; Dempsey OJ; Lee DK
QJM; 2005 Mar; 98(3):171-82. PubMed ID: 15728398
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of long-acting beta2-agonists, leukotriene receptor antagonists, and a 5-lipoxygenase inhibitor on exercise-induced asthma.
Coreno A; Skowronski M; Kotaru C; McFadden ER
J Allergy Clin Immunol; 2000 Sep; 106(3):500-6. PubMed ID: 10984370
[TBL] [Abstract][Full Text] [Related]
8. [The use of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in bronchial asthma treatment].
Kuziemski K; Mincewicz G; Sopel R; Słomiński JM
Pol Merkur Lekarski; 1998 Dec; 5(30):317-20. PubMed ID: 10101512
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
Diamant Z; Dekhuijzen PN
Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1681-5. PubMed ID: 14513539
[TBL] [Abstract][Full Text] [Related]
10. Critical appraisal of antileukotriene use in asthma management.
Polosa R
Curr Opin Pulm Med; 2007 Jan; 13(1):24-30. PubMed ID: 17133121
[TBL] [Abstract][Full Text] [Related]
11. [Novel treatment of bronchial asthma: application of leukotriene receptor antagonists and leukotriene synthesis inhibitors].
Diamant Z; Sterk PJ
Ned Tijdschr Geneeskd; 1998 Jan; 142(5):72-8. PubMed ID: 12013053
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of montelukast in the treatment of cough variant asthma.
Spector SL; Tan RA
Ann Allergy Asthma Immunol; 2004 Sep; 93(3):232-6. PubMed ID: 15478381
[TBL] [Abstract][Full Text] [Related]
13. Advances in therapy with antileukotriene drugs.
Riccioni G; Di Ilio C; Conti P; Theoharides TC; D'Orazio N
Ann Clin Lab Sci; 2004; 34(4):379-87. PubMed ID: 15648777
[TBL] [Abstract][Full Text] [Related]
14. Leukotriene antagonists. Do they offer new hope for asthmatics?
Thien F
Aust Fam Physician; 2000 Jun; 29(6):547-51. PubMed ID: 10863810
[TBL] [Abstract][Full Text] [Related]
15. [Influence of leukotriene receptor antagonists on prognosis of patients with bronchial asthma].
Nagata M
Arerugi; 2007 Nov; 56(11):1408. PubMed ID: 18059156
[No Abstract] [Full Text] [Related]
16. Impact of montelukast on asthma associated with rhinitis, and other triggers and co-morbidities.
Pacheco Y; Freymond N; Devouassoux G
J Asthma; 2014 Feb; 51(1):1-17. PubMed ID: 23834429
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of airway inflammation in mild intermittent asthma.
van den Toorn LM
Ann Allergy Asthma Immunol; 2004 Jun; 92(6):589-94; quiz 595-7, 658. PubMed ID: 15237759
[TBL] [Abstract][Full Text] [Related]
18. [Current recommendation for asthma treatment].
Kuna P
Pol Merkur Lekarski; 2004 May; 16 Suppl 1():24-9. PubMed ID: 15524009
[TBL] [Abstract][Full Text] [Related]
19. Effect of cysteinyl leukotriene receptor antagonist on CD11b and CD23 expression in asthmatic children.
Gagro A; Aberle N; Rabatić S; Ajduk J; Jelacić J; Dekaris D
Clin Exp Allergy; 2004 Jun; 34(6):939-44. PubMed ID: 15196283
[TBL] [Abstract][Full Text] [Related]
20. Leukotriene modifiers in the treatment of asthma in children.
del Giudice MM; Pezzulo A; Capristo C; Alterio E; Caggiano S; de Benedictis D; Capristo AF
Ther Adv Respir Dis; 2009 Oct; 3(5):245-51. PubMed ID: 19822630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
